|Bid||130.10 x 1000|
|Ask||131.95 x 1800|
|Day's Range||129.45 - 131.18|
|52 Week Range||118.62 - 148.99|
|Beta (3Y Monthly)||0.62|
|PE Ratio (TTM)||229.68|
|Earnings Date||Jan 22, 2019|
|Forward Dividend & Yield||3.60 (2.79%)|
|1y Target Est||145.50|
World Economic Forum gathers in Davos, Switzerland, government shutdown continues and earnings week two, here's what you need to know next week.
What about all of the intelligentsia that come on air and tell us that the Chinese are playing the long game and we'll lose in the end? Well, I think they aren't businesspeople. What's really amazing is how universally contemptuous businesspeople are of the Chinese.
NEW ORLEANS , Jan. 18, 2019 /PRNewswire/ -- Former Attorney General of Louisiana , Charles C. Foti, Jr., Esq. , a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF ...
Twelve weeks a year, investors need to be on the top of their game, Jim Cramer told his Mad Money viewers Friday. Cramer remained a fan of the deal. Cramer was a fan of Comcast's bid to buy Sky, and also liked the outlooks for both Procter and the very consistent Abbott Labs.
CNBC's Jim Cramer looks ahead at a busy week of earnings reports that he says might drive investors crazy. Johnson & Johnson, Comcast and Starbucks will be among the companies issuing quarterly results. "I can't recall a time when the forecast will be more important, certainly much more important than the results," Cramer, host of "Mad Money," told viewers.
AbbVie Inc said on Friday its blockbuster cancer treatment in combination with chemotherapy agents failed to meet the main goal in a late-stage study of patients with a form of pancreatic cancer. The treatment, Imbruvica, failed to show statistically significant improvement in progression-free survival (PFS) or overall survival in metastatic pancreatic cancer patients, compared with the combination of placebo and two chemotherapy agents. The American Cancer society estimates that pancreatic cancer accounts for about 3 percent of all cancers in the United States and about 7 percent of all cancer deaths, and expects that 56,770 people will be diagnosed with pancreatic cancer in 2019.
The major benchmarks made gains, but Netflix fell despite reporting a strong quarter. Elsewhere, Apple and Johnson & Johnson announced a new collaboration.
Apple (AAPL) partners with Johnson & Johnson to conduct multi-year research study for early detection of irregular heart conditions.